Cargos activos de Philippe Halfon
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Genoscience Pharma
 Genoscience Pharma BiotechnologyHealth Technology Genoscience Pharma is a French clinical-stage biotechnology company that develops novel lysosomotropic therapeutics to establish a new standard of care against cancer, autoimmune, and infectious diseases. The private company is based in Marseille, France and was founded in 2001 by Philippe Halfon. Its lead candidate, GNS561, is a phase 2 ready drug candidate that tackles cancer cells through autophagy modulation. Genoscience Pharma is also entering a phase 2 trial with GNS561. | Director/Miembro de la Junta | 01/01/2001 | - |
| Fundador | 01/01/2001 | - | |
| Presidente | 01/01/2001 | - |
Historial de carrera de Philippe Halfon
Estadísticas
Internacional
| Francia | 2 |
Operativa
| Director/Board Member | 1 |
| Founder | 1 |
| President | 1 |
Sectorial
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Genoscience Pharma
Genoscience Pharma BiotechnologyHealth Technology Genoscience Pharma is a French clinical-stage biotechnology company that develops novel lysosomotropic therapeutics to establish a new standard of care against cancer, autoimmune, and infectious diseases. The private company is based in Marseille, France and was founded in 2001 by Philippe Halfon. Its lead candidate, GNS561, is a phase 2 ready drug candidate that tackles cancer cells through autophagy modulation. Genoscience Pharma is also entering a phase 2 trial with GNS561. | Health Technology |
- Bolsa de valores
- Insiders
- Philippe Halfon
- Experiencia
